PEG/PEI-functionalized single-walled carbon nanotubes as delivery carriers for doxorubicin: synthesis, characterization, and in vitro evaluation

• Shuoye Yang,
• Zhenwei Wang,
• Yahong Ping,
• Yuying Miao,
• Yongmei Xiao,
• Lingbo Qu,
• Lu Zhang,
• Yuansen Hu and
• Jinshui Wang

Beilstein J. Nanotechnol. 2020, 11, 1728–1741, doi:10.3762/bjnano.11.155

• evaluated in terms of drug loading, in vitro release, cytotoxicity towards MCF-7 cells and cellular uptake. The results showed that all CNT carriers had a high drug loading capacity. In comparison with CNTs-COOH and CNTs-PEG, CNTs-PEG-PEI showed a more rapid drug release under acidic conditions and a higher

• ) and encapsulation efficiency (EE) were determined as: LE = weight of encapsulated DOX/weight of DOX-loaded carriers and EE (%) = weight of encapsulated DOX/weight of the total DOX·100%. In vitro drug release The release of DOX from the nanocarriers was examined in PBS at pH 7.4 and pH 5.0 [34

• modification with PEG or PEI [40]. It should be noted that LE and EE of CNT carriers in this study are higher than those of other nanocarriers such as mesoporous silica nanoparticles (MSNs) or liposomes [39]. In vitro drug release Due to the encapsulation in the nanocarriers after drug loading, a premature

Transient coating of γ-Fe₂O₃ nanoparticles with glutamate for its delivery to and removal from brain nerve terminals

• Konstantin Paliienko,
• Artem Pastukhov,
• Michal Babič,
• Daniel Horák,
• Olga Vasylchenko and
• Tatiana Borisova

Beilstein J. Nanotechnol. 2020, 11, 1381–1393, doi:10.3762/bjnano.11.122

• drug release from nanoparticles to manipulate neuronal cells [9][15]. Release of receptor agonists and antagonists from thermally sensitive magnetoliposomes loaded with iron oxide magnetic nanoparticles can be remotely controlled by weak alternating magnetic fields facilitating the modulation of

Photothermally active nanoparticles as a promising tool for eliminating bacteria and biofilms

• Mykola Borzenkov,
• Piersandro Pallavicini,
• Angelo Taglietti,
• Laura D’Alfonso,
• Maddalena Collini and
• Giuseppe Chirico

Beilstein J. Nanotechnol. 2020, 11, 1134–1146, doi:10.3762/bjnano.11.98

• drug release [41][42], in addition to new quantitative tools for biochemical analysis [43] and photothermally induced cell stimulation [44][45]. Since bacteria and biofilm photothermal ablation is another promising application that is currently being widely investigated, this review will highlight the

Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements

• Maria Suciu,
• Corina M. Ionescu,
• Alexandra Ciorita,
• Septimiu C. Tripon,
• Dragos Nica,
• Hani Al-Salami and
• Lucian Barbu-Tudoran

Beilstein J. Nanotechnol. 2020, 11, 1092–1109, doi:10.3762/bjnano.11.94

• applications [65][66]. Some authors state that SPIONs having sizes between 5 and 10 nm are best for certain slow drug release treatments [46], however, others report that these ultrasmall SPIONs are dangerous due to their large in-tissue dispersity [67]. Other reports suggest that very small (less than 10 nm

• release at the targeted site. A functionalization that permits only adsorption can lead to premature drug release [33][46][80]. Mojica Pisciotti and co-workers [39] studied the effects of dextran and PEG coatings on two animal kidney cell lines and showed that dextran-coated SPIONs are not cytotoxic even

• PVA or PEG, for drug release studies [33][76] because the hydrophobic polymers are rapidly uptaken by macrophages [85]. SPIONs coated with a mixture of PVA and polyvinyl amine were shown to induce very active mitochondrial and endocytic processes in cells and to be highly toxic to cells due to the

A 3D-polyphenylalanine network inside porous alumina: Synthesis and characterization of an inorganic–organic composite membrane

• Jonathan Stott and
• Jörg J. Schneider

Beilstein J. Nanotechnol. 2020, 11, 938–951, doi:10.3762/bjnano.11.78

• well as the mechanisms of gel formation have been studied in detail. Hydrophilic gels with functional side groups enable stimuli-responsive hydrogels with interesting properties with regards to drug release systems. A drawback of these gels is their low mechanical stability, which can however be

• -grafted gel might be interesting in membrane separation technology or supported drug release/adsorption systems. We investigate the ability of polyphenylalanine to form organo-gels in situ within a porous inorganic environment with respect to different volume fractions of DCM in the solvent mixture. We

Luminescent gold nanoclusters for bioimaging applications

• Nonappa

Beilstein J. Nanotechnol. 2020, 11, 533–546, doi:10.3762/bjnano.11.42

• be identical with a fast release up to 6 h and a slow release up to 20 h in PBS buffer, possibly due to diffusion-driven drug release. DPML-MF remained stable in human blood serum up to 24 h. DPML-MF showed a significant effect on HeLa, HepG2 and A375 cell lines with IC50 values 200-fold higher

Multilayer capsules made of weak polyelectrolytes: a review on the preparation, functionalization and applications in drug delivery

• Varsha Sharma and
• Anandhakumar Sundaramurthy

Beilstein J. Nanotechnol. 2020, 11, 508–532, doi:10.3762/bjnano.11.41

• drug release time could be extended by increasing the crystal size and thickness of the multilayer films. Alternatively, the protein aggregates or DNA could also be used as templates to encapsulate them in PLL-succinylated PLL layers for model viral assembly or gene transfer [66]. Another way of

Nanoarchitectonics: bottom-up creation of functional materials and systems

• Katsuhiko Ariga

Beilstein J. Nanotechnol. 2020, 11, 450–452, doi:10.3762/bjnano.11.36

• ] gives insight into this interesting field of research which has great potential. The nanoarchitectonics concept has been applied for various bio-related applications, for example, in the small-protein-induced cellular uptake of complex nanohybrids [30], the controlled drug release from layered double

Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine

• Valentina Francia,
• Daphne Montizaan and
• Anna Salvati

Beilstein J. Nanotechnol. 2020, 11, 338–353, doi:10.3762/bjnano.11.25

• intracellular locations or to promote drug release in cells. 4 Challenges in studying endocytosis of nano-sized materials in vitro While studying the interactions between nanomaterials and cells is extremely challenging to perform in vivo, in vitro studies can help to unravel the mechanisms involved in their

Facile biogenic fabrication of hydroxyapatite nanorods using cuttlefish bone and their bactericidal and biocompatibility study

• Satheeshkumar Balu,
• Manisha Vidyavathy Sundaradoss,
• Swetha Andra and
• Jaison Jeevanandam

Beilstein J. Nanotechnol. 2020, 11, 285–295, doi:10.3762/bjnano.11.21

• loading capacity and slow drug release in drug delivery systems for progressive advancement in osteoporosis and bone tumor treatments [17]. Various studies have reported the synthesis procedure of Hap nanoparticles from annealed cuttlefish bone using a hydrothermal method, which yields calcium oxide (CaO

Rational design of block copolymer self-assemblies in photodynamic therapy

• Maxime Demazeau,
• Laure Gibot,
• Anne-Françoise Mingotaud,
• Patricia Vicendo,
• Clément Roux and
• Barbara Lonetti

Beilstein J. Nanotechnol. 2020, 11, 180–212, doi:10.3762/bjnano.11.15

• the production of ROS upon irradiation. Stimuli-responsive vectors This strategy has been examined a lot during the last years, in a general manner for nanomedicine but also for PDT. As already explained above, the principle is to benefit from the biological medium environment to trigger the drug

• release (the PS for PDT). The decrease in pH value in cancer tissues has been regularly used in nanomedicine to break a pH-sensitive bond leading to the dissociation of the vector and the subsequent release of the drug [80]. Recently, several studies focused on hypoxia, which might be considered as a

Fully amino acid-based hydrogel as potential scaffold for cell culturing and drug delivery

• Dávid Juriga,
• Evelin Sipos,
• Orsolya Hegedűs,
• Gábor Varga,
• Miklós Zrínyi,
• Krisztina S. Nagy and
• Angéla Jedlovszky-Hajdú

Beilstein J. Nanotechnol. 2019, 10, 2579–2593, doi:10.3762/bjnano.10.249

• established. Using metoprolol as a model drug, cell proliferation and drug release kinetics were studied at different LYS contents and in the presence of thiol groups. The optimal ratio of cross-linkers for the proliferation of periodontal ligament cells was found to be 60−80% LYS and 20−40% CYS. The

• reductive conditions resulted in an increased drug release due to the cleavage of disulfide bridges in the hydrogels. Consequently, these hydrogels provide new possibilities in the fields of both tissue engineering and controlled drug delivery. Keywords: biocompatibility; cystamine; hydrogel; lysine; poly

• improve the pharmacological and therapeutic properties of various drugs [28]. By applying such microcarriers, the drug release kinetics can be controlled. Among the anionic amino acids, glutamic acid was previously used for the preparation of polymer-based microcarriers [33]. However, there are only

Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells

• Mohammad J. Akbar,
• Pâmela C. Lukasewicz Ferreira,
• Melania Giorgetti,
• Leanne Stokes and
• Christopher J. Morris

Beilstein J. Nanotechnol. 2019, 10, 2553–2562, doi:10.3762/bjnano.10.246

• these nanocarriers, particularly with regards to their efficiency of carrying chemotherapeutic agents into the cell. Poor intracellular accumulation of nanocarriers can be improved through targeted and triggered drug release, for example through the incorporation of temperature-sensitive [32] or light

Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects

• Sabrina Barbosa de Souza Ferreira,
• Gustavo Braga,
• Évelin Lemos Oliveira,
• Jéssica Bassi da Silva,
• Hélen Cássia Rosseto,
• Lidiane Vizioli de Castro Hoshino,
• Mauro Luciano Baesso,
• Wilker Caetano,
• Craig Murdoch,
• Helen Elizabeth Colley and
• Marcos Luciano Bruschi

Beilstein J. Nanotechnol. 2019, 10, 2304–2328, doi:10.3762/bjnano.10.222

• for their chemical, rheological, mechanical and mucoadhesive characteristics. We also measured the in vitro drug release profile, permeation and the cytotoxic potential of these systems. Results and Discussion Interaction studies of curcumin in mucoadhesive nanostructured systems As CUR is highly

• fluorescence quenching, using iodide as a hydro-soluble suppressor [2][52][53][54]. The studies were performed at 25 °C (room and administration temperature) and 37 °C (body temperature). Using this assay, it is possible to evaluate the location of CUR in the polymeric system during drug release and to

• with the mechanical and rheological characteristics observed. One of the replicate images is showed in Figure 9B. In vitro drug release profile During the development of drug delivery systems for buccal application, in vitro drug release is highly important and is considered a prerequisite for

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe₂O₄/silica/cisplatin nanocomposite formulation

• B. Rabindran Jermy,
• Vijaya Ravinayagam,
• Widyan A. Alamoudi,
• Dana Almohazey,
• Hatim Dafalla,
• Lina Hussain Allehaibi,
• Abdulhadi Baykal,
• Muhammet S. Toprak and
• Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

• expected health crisis [1]. However, the single modal drug delivery system is hampered by low bioavailability (about 5–10%), burst release, and lower target efficiency. Multifunctional theranostic nanoparticles that can respond to an external magnetic field for drug release and assist in bioimaging

• for 30 min. A droplet (5 µL) of diluted suspension was deposited in a 300-mesh pure carbon grid and then kept in a pumping station for 1 h for further drying. The grids were examined by the JEM2100F instrument from JEOL. Drug release study The cumulative cisplatin release was studied using CuFe2O4

• and 600 nm shows the presence of octahedral coordinated Pt species (Figure 6b). The presence of such strong bonds of tetrahedral and octahedral Pt species indicates the high dispersity and interaction of Pt on HYPS silica support. The drug release ability of CuFe2O4/HYPS was compared with two

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity

• Sebastian Pieper,
• Hannah Onafuye,
• Dennis Mulac,
• Jindrich Cinatl Jr.,
• Mark N. Wass,
• Martin Michaelis and
• Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201

• -like kinetics of the other preparations. In neuroblastoma cells, doxorubicin-loaded PLGA-PEG nanoparticles (presumably due to their small size) and PLGA nanoparticles prepared by solvent displacement at pH 7 (presumably due to their high drug load and superior drug release kinetics) exerted the

• their anticancer activity at the cellular level. Optimised preparation methods resulted in PLGA nanoparticles characterised by increased drug load, controlled drug release, and high anticancer efficacy. The design of drug-loaded nanoparticles with optimised anticancer activity at the cellular level is

• an important step in the development of improved nanoparticle preparations for anticancer therapy. Further research is required to understand under which circumstances nanoparticles can be used to overcome efflux-mediated resistance in cancer cells. Keywords: cancer; doxorubicin; drug release

Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells

• Liang Xu,
• Dekang Xu,
• Ziying Li,
• Yu Gao and
• Haijun Chen

Beilstein J. Nanotechnol. 2019, 10, 1933–1942, doi:10.3762/bjnano.10.189

• the lungs will be quickly eliminated due to large alveolar surface area, abundant capillaries and minimal transport distance, the sustained drug release delivery systems will improve the drug absorption and increase the activities [38]. Compared with DiP, P2P still showed better antiproliferative

Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release

• Mohammad A. Obeid,
• Ibrahim Khadra,
• Abdullah Albaloushi,
• Margaret Mullin,
• Hanin Alyamani and
• Valerie A. Ferro

Beilstein J. Nanotechnol. 2019, 10, 1826–1832, doi:10.3762/bjnano.10.177

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells

• Hannah Onafuye,
• Sebastian Pieper,
• Dennis Mulac,
• Jindrich Cinatl Jr.,
• Mark N. Wass,
• Klaus Langer and
• Martin Michaelis

Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166

• doxorubicin-loaded HSA (40%) nanoparticles. Together, these data confirm that administration of doxorubicin as HSA nanoparticles resulted in the circumvention of ABCB1-mediated drug efflux. The difference between HSA (40%) nanoparticles and the other two preparations may be explained by elevated drug release

• due to the lower degree of cross-linking. Interestingly, high concentrations of the cross-linker glutaraldehyde did not affect the efficacy of the resulting doxorubicin-loaded nanoparticles although high glutaraldehyde concentrations might have been expected to affect drug release and/or to covalently

• paclitaxel with albumin may differ from that of doxorubicin. Hence, variations in drug binding and drug release kinetics may be responsible for this difference. Despite the prominent role of ABCB1 as a drug resistance mechanism, attempts to exploit it as drug target have failed so far, despite the

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• provided unique advantages such as the possibility to transport highly lipophilic drugs and to improve the pharmacokinetic profile of these drugs, enhancing their accumulation both in the tumoral tissue and within the malignant cells. Moreover, it is even possible to control the drug release process

• through the incorporation of stimuli-responsive mechanisms that regulate the drug release from the nanocarrier. The incorporation of targeting moieties on the carrier surface produces a significative increase in the particle accumulation inside tumoral cells, which could improve the efficacy of the

Characterization and influence of hydroxyapatite nanopowders on living cells

• Przemyslaw Oberbek,
• Tomasz Bolek,
• Adrian Chlanda,
• Seishiro Hirano,
• Sylwia Kusnieruk,
• Julia Rogowska-Tylman,
• Ganna Nechyporenko,
• Viktor Zinchenko,
• Wojciech Swieszkowski and
• Tomasz Puzyn

Beilstein J. Nanotechnol. 2018, 9, 3079–3094, doi:10.3762/bjnano.9.286

• delivery or more effective gene transfection based on hydroxyapatite. The degree of crystallinity can be a factor in determining how long an agglomerate will stay inside the cell and what will be the drug-release rate. Hydroxyapatites with exceptionally large surface area could be also used for

Enhanced antineoplastic/therapeutic efficacy using 5-fluorouracil-loaded calcium phosphate nanoparticles

• Shanid Mohiyuddin,
• Saba Naqvi and
• Gopinath Packirisamy

Beilstein J. Nanotechnol. 2018, 9, 2499–2515, doi:10.3762/bjnano.9.233

• the drug-loaded nanoparticles (CaP@5-FU). This might be due to fact that the drug was loaded in the aqueous core of the nanoparticles [26]. Furthermore, upon drug loading, insignificant changes were found in the absorption spectrum of the nanoparticles. pH-triggered drug release study To understand

• the rate of 5-FU release from CaP@5-FU NPs, we employed the dialysis bag method. An acidic (in vitro model for the tumour microenvironment) condition correlates with drug release in the acidic tumour regime. On the other hand, physiological conditions at pH 7.4 represent the healthy cell environment

• the acidic microenvironment [25]. In our study, we demonstrated a biphasic release of 5-FU from CaP@5-FU NPs with the characteristic initial burst release followed by slow and sustained release [27]. Within 12 hours, only 36% drug release in physiological pH was shown, whereas 47% was released in

Biomimetic and biodegradable cellulose acetate scaffolds loaded with dexamethasone for bone implants

• Aikaterini-Rafailia Tsiapla,
• Varvara Karagkiozaki,
• Veroniki Bakola,
• Foteini Pappa,
• Panagiota Gkertsiou,
• Eleni Pavlidou and
• Stergios Logothetidis

Beilstein J. Nanotechnol. 2018, 9, 1986–1994, doi:10.3762/bjnano.9.189

• . Cytotoxicity studies were performed by using MTT assay, methylene-blue staining and SEM fixation and showed very good cell adhesion and proliferation, indicating the cytocompatibility of these fibrous scaffolds. Drug-release kinetics was measured for the evaluation of a controllable and sustained release of

• devices [15][16][17]. The use of micro- and nanofibers as carriers for drug release is more efficient because the drug is locally released to the target organ or tissue and as a result less amount of drug is required with fewer side effects [18][19]. Inflammation is the most common cause of aseptic

• is created [23]. Grounded aluminum foils, glass substrates and also coatings for orthopaedic pins were used as collectors to carry out the necessary studies. Drug-release kinetics and degradation study of scaffolds Degradation study was carried out in order to evaluate the mass loss of polymer and

A visible-light-controlled platform for prolonged drug release based on Ag-doped TiO₂ nanotubes with a hydrophobic layer

• Caihong Liang,
• Jiang Wen and
• Xiaoming Liao

Beilstein J. Nanotechnol. 2018, 9, 1793–1801, doi:10.3762/bjnano.9.170

• Caihong Liang Jiang Wen Xiaoming Liao College of Materials Science and Engineering, Sichuan University, Chengdu, Sichuan 610065, China 10.3762/bjnano.9.170 Abstract In this work, a visible-light-controlled drug release platform was constructed for localized and prolonged drug release based on two

• layer. To demonstrate the visible-light-controlled drug release, the Zn2+ release behavior of the samples was investigated. In the initial 12 h, TNTs without NDM displayed a faster release rate with 29.4% Zn2+ release, which was more than three times that of the TNTs with NDM (8.7% Zn2+ release). Upon

• visible-light illumination, drug release from the sample coated with NDM was shown to increase due to the photocatalytic decomposition of NDM. The amount of released Zn2+ for this sample increased up to 71.9% within 12 h, indicating visible-light-controlled drug release. This drug release system may

Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules

• María Francisca Matus,
• Martín Ludueña,
• Cristian Vilos,
• Iván Palomo and
• Marcelo M. Mariscal

Beilstein J. Nanotechnol. 2018, 9, 1328–1338, doi:10.3762/bjnano.9.126

• explorative tool or as a complementary approach to experiments, which is useful for the rational design of new drug delivery systems. In future work, this approximation will be correlated with maximum drug loading determined experimentally and the protective role of differentially charged PEG for drug release